Similarly, CXCL10 levels were significantly higher in serum of CIDP patients (115 ± 10 pg/mL) than in HBDS (81 ± 7 pg/mL; p < 0.01) and ONDs (60 ± 13 pg/mL; p < 0.001). This evidence concerns the gene CXCL10 and chronic inflammatory demyelinating polyradiculoneuropathy.